Skip to main content
. 2020 Jan 10;2020:8459303. doi: 10.1155/2020/8459303

Figure 2.

Figure 2

Immunohistochemical expression of pretreatment biomarkers. (a) MSH6 expression showing an unstableness (×400). (b) Expression of 80% of nuclear Ki67 (×400). (c) Nuclear expression of p53 (×20). (d) Expression of HER-2 showing a score 3+ (×20).